Literature DB >> 11734103

Cognitive Impairment Following Traumatic Brain Injury.

David B. Arciniegas1, Kerri Held, Peter Wagner.   

Abstract

Cognitive impairments due to traumatic brain injury (TBI) are substantial sources of morbidity for affected individuals, their family members, and society. Disturbances of attention, memory, and executive functioning are the most common neurocognitive consequences of TBI at all levels of severity. Disturbances of attention and memory are particularly problematic, as disruption of these relatively basic cognitive functions may cause or exacerbate additional disturbances in executive function, communication, and other relatively more complex cognitive functions. Because of the high rate of other physical, neurologic, and psychiatric syndromes following TBI, a thorough neuropsychiatric assessment of the patient is a prerequisite to the prescription of any treatment for impaired cognition. Psychostimulants and other dopaminergically active agents (eg, methylphenidate, dextroamphetamine, amantadine, levodopa/carbidopa, bromocriptine) may modestly improve arousal and speed of information processing, reduce distractibility, and improve some aspects of executive function. Cautious dosing (start-low and go-slow), frequent standardized assessment of effects and side effects, and monitoring for drug-drug interactions are recommended. Cognitive rehabilitation is useful for the treatment of memory impairments following TBI. Cognitive rehabilitation may also be useful for the treatment of impaired attention, interpersonal communication skills, and executive function following TBI. This form of treatment is most useful for patients with mild to moderate cognitive impairments, and may be particularly useful for those who are still relatively functionally independent and motivated to engage in and rehearse these strategies. Psychotherapy (eg, supportive, individual, cognitive-behavioral, group, and family) is an important component of treatment. For patients with medication- and rehabilitation-refractory cognitive impairments, psychotherapy may be needed to assist both patients and families with adjustment to permanent disability.

Entities:  

Year:  2002        PMID: 11734103     DOI: 10.1007/s11940-002-0004-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  40 in total

1.  Brain injury, cognitive impairment, and donepezil.

Authors:  J A Whitlock
Journal:  J Head Trauma Rehabil       Date:  1999-08       Impact factor: 2.710

2.  Protracted post-traumatic confusional state treated with physostigmine.

Authors:  P Eames; A Sutton
Journal:  Brain Inj       Date:  1995-10       Impact factor: 2.311

3.  Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion.

Authors:  K Kmieciak-Kołada; W Felińska; Z Stachura; H Majchrzak; Z S Herman
Journal:  Pol J Pharmacol Pharm       Date:  1987 Jan-Feb

4.  Cortical cholinergic dysfunction after human head injury.

Authors:  I Murdoch; E K Perry; J A Court; D I Graham; D Dewar
Journal:  J Neurotrauma       Date:  1998-05       Impact factor: 5.269

5.  Clinical use of amantadine in brain injury rehabilitation.

Authors:  J L Nickels; W N Schneider; M L Dombovy; T M Wong
Journal:  Brain Inj       Date:  1994 Nov-Dec       Impact factor: 2.311

6.  Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia.

Authors:  E Goldberg; L J Gerstman; S Mattis; J E Hughes; C A Sirio; R M Bilder
Journal:  J Clin Neuropsychol       Date:  1982-09

7.  Catecholamines predict outcome in traumatic brain injury.

Authors:  R W Hamill; P D Woolf; J V McDonald; L A Lee; M Kelly
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

8.  Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients.

Authors:  S McDowell; J Whyte; M D'Esposito
Journal:  Brain       Date:  1998-06       Impact factor: 13.501

9.  Head injury with and without hospital admission: comparisons of incidence and short-term disability.

Authors:  D Fife
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

10.  The predictive value of catecholamines in assessing outcome in traumatic brain injury.

Authors:  P D Woolf; R W Hamill; L A Lee; C Cox; J V McDonald
Journal:  J Neurosurg       Date:  1987-06       Impact factor: 5.115

View more
  56 in total

1.  Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans.

Authors:  Giulio M Pasinetti; Lap Ho; Christopher Dooley; Bhavna Abbi; Gudrun Lange
Journal:  Am J Neurodegener Dis       Date:  2012-04-24

2.  Are self-reported symptoms of executive dysfunction associated with objective executive function performance following mild to moderate traumatic brain injury?

Authors:  Dawn M Schiehser; Dean C Delis; J Vincent Filoteo; Lisa Delano-Wood; S Duke Han; Amy J Jak; Angela I Drake; Mark W Bondi
Journal:  J Clin Exp Neuropsychol       Date:  2011-07       Impact factor: 2.475

3.  Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury.

Authors:  Ali Alawieh; E Farris Langley; Shannon Weber; DeAnna Adkins; Stephen Tomlinson
Journal:  J Neurosci       Date:  2018-02-06       Impact factor: 6.167

4.  Alterations of connectivity patterns in functional brain networks in patients with mild traumatic brain injury: A longitudinal resting-state functional magnetic resonance imaging study.

Authors:  Maria M D'Souza; Mukesh Kumar; Ajay Choudhary; Prabhjot Kaur; Pawan Kumar; Poonam Rana; Richa Trivedi; Tarun Sekhri; Ajay K Singh
Journal:  Neuroradiol J       Date:  2020-01-28

5.  Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury.

Authors:  Jenny B Koenig; David Cantu; Cho Low; Mary Sommer; Farzad Noubary; Danielle Croker; Michael Whalen; Dong Kong; Chris G Dulla
Journal:  JCI Insight       Date:  2019-04-30

6.  Diffuse Disconnectivity in tBi: a resting state fMri anD Dti stuDy.

Authors:  Cheuk Ying Tang; Emily Eaves; Kristen Dams-O'Connor; Lap Ho; Eric Leung; Edmund Wong; David Carpenter; Johnny Ng; Wayne Gordon; Giulio Pasinetti
Journal:  Transl Neurosci       Date:  2012-03-01       Impact factor: 1.757

7.  Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI).

Authors:  Golam Mustafa; Jiamei Hou; Shigeharu Tsuda; Rachel Nelson; Ankita Sinharoy; Zachary Wilkie; Rahul Pandey; Robert M Caudle; John K Neubert; Floyd J Thompson; Prodip Bose
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

8.  Proton MR spectroscopy and MRI-volumetry in mild traumatic brain injury.

Authors:  B A Cohen; M Inglese; H Rusinek; J S Babb; R I Grossman; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 9.  Cognitive reserve in stroke and traumatic brain injury patients.

Authors:  Domenica Nunnari; Placido Bramanti; Silvia Marino
Journal:  Neurol Sci       Date:  2014-07-23       Impact factor: 3.307

10.  Correlations between event-related potentials with pictures recognition and WMS-RC scores in patients with memory disorder caused by severe traumatic brain injury.

Authors:  Zilong Liu; Liang Liu; Zebing Fan; Xiaorui Chen; Xiaohong Zhao; Lingli Zhang; Guangxun Rao; Haixia Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.